Silencing L-selectin expression by siRNA attenuated metastasis of murine lymphoid neoplasm cell P388D1 to peripheral lymph nodes
Y Zuo,W Wei,C Liu,L Zhao,L Wang,J Zhang
DOI: https://doi.org/10.1038/sj.leu.2404469
2006-01-01
Leukemia
Abstract:About 50% of tumor metastasis is via the lymphatic system, but the underlying mechanisms have not been characterized. L-selectin (CD62L) is a lymphocyte homing receptor that is important for the migration of lymphocytes into peripheral lymph nodes.1 It is an intriguing question whether lymphoma cells use the same pathways of dissemination into peripheral lymph nodes.2, 3 In this work, we sought to ascertain whether the expression of L-selectin on macrophage-like lymphoid neoplasm P388D1 cells would facilitate their localization to peripheral lymph nodes. First, L-selectin mRNA in P388D1 cells and L-selectin protein on P388D1 cell surface were detected by reverse transcriptase–polymerase chain reaction (RT–PCR) and flow cytometry method (FCM) (data not shown), respectively, whereas C57BL/6 mouse splenic lymphocytes were used as a positive control of L-selectin expression (Figure 1a). Then, L-selectin expressions on P388D1 cells were silenced by L-selectin small interferring RNA (siRNA) approach. In our experiment, both L-selectin siRNA, a target-specific 20–25 nt siRNA designed to knockdown L-selectin expression, and control siRNA which has no significant sequence homology with mRNA databases were from Santa Cruz Biotechnology, CA, USA. P388D1 cells were transfected with L-selectin siRNA and control siRNA, respectively, along with Effectene transfection reagent, following the manufacturer's instructions. After 30 h, L-selectin siRNA transfection dramatically reduced L-selectin expressions on P388D1 cells, whereas the control siRNA had no such effect (Figure 1b). Further observation showed L-selectin expression did not recover to original level until 14 days after siRNA transfection (data not shown). 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay showed L-selectin siRNA, control siRNA and the Effectene transfection reagent did not affect P388D1 cell growth curve, suggesting these regents have no cytotoxic effect on P388D1 cells. Similar results were observed after incubation of P388D1 cells with MEL-14 (anti-L-selectin mAB, BD Pharmagen (San Diego, CA, USA), Rat-immunoglobulin (IgG), (Sigma, St Louis, MO, USA) and carboxyfluorescein diacetate succinimidyl ester (CFSE) (Fluka, Deisenhofen, Germany), which were used in the experiments below (Figure 1c). To analyse whether L-selectin mediates the adhesion of P388D1 cells to the lymphatic endothelium, Stamper–Woodruff assays were performed with little modification.4 In brief, 3 105 of P388D1 cells in 200-l cell suspension was overlaid onto the frozen sections of DAB mouse lymph nodes, and the sections were maintained in static conditions for 15 min at 37°C, followed by 5 min of rotation at 60 r.p.m., and thereafter again kept under static conditions for 15 min at 7°C. The sections were fixed in 1% (v/v) glutaraldehyde for 5 min and stained with hematoxylin and eosin (HE) before the assay. In this experiment, P388D1 cells could adhere to both lymphatic sinusoids and marginal sinusoids (data not shown). The number of adherent cells on the sum of lymphatic sinusoids and marginal sinusoids was quantified by using Image-Pro Plus software (Media Cybernetics, Silver Spring, MD, USA). The results showed that the adherent cell number of P388D1 cell with MEL-14 (1:100) pretreatment was less than that with Rat IgG treatment, suggesting the adhesion of P388D1 cells to the sum of lymphatic sinusoids and marginal sinusoid in vitro can be blocked by L-selectin antibody (Figure 2a). Furthermore, after L-selectin expression was reduced by L-selectin siRNA transfection, the adhesive ability of P388D1 cells to the sum of lymphatic sinusoids and marginal sinusoids decreased significantly, as compared with control siRNA transfection (Figure 2a). These data indicated that L-selectin on P388D1 cells mediates its adhesion to the lymphatic endothelium, and silencing L-selectin expression on P388D1 cells resulted in inhibition of adhesion of P388D1 cells to lymphatic sinusoids and marginal sinusoid in vitro. Next, we investigated whether siRNA-induced L-selectin expression silencing affect P388D1 cells adhesion on to lymphatic endothelium in vivo. For this purpose, P388D1 cells were labeled with 5 M CFSE, a green fluorescence dye which can be transported across plasma membrane to react covalently with free amino group of intracellular macromolecules.5 In brief, two groups of DAB mice (n=6) received footpad injections of CFSE-tagged P388D1 cells transfected with L-selectin siRNA or control siRNA, 1 107 cells for each recipient. After 1-48 h, the mice were killed. Peripheral lymph nodes were removed and CFSE-tagged P388D1 cells in cell suspensions were evaluated by flow cytometry. A significant reduction of CFSE-tagged P388D1 cells population in popliteal nodes other than inguinal and axillary nodes was observed after 12 h in L-selectin siRNA-treated groups (Figure 2b). Similarly, two groups received footpad injections of CFSE-tagged P388D1 cells preincubated with 500 ng of MEL-14 or 500 ng of rat IgG, 1 107 cells for each recipient. In the MEL-14-treated group, CFSE-tagged P388D1 cells adhesion to popliteal and inguinal nodes but not axillary nodes was significantly lower than that in the control group at 12 h (Figure 2b). These data indicate that L-selectin on P388D1 cells plays an important role in adhesion to peripheral lymph nodes not only in vitro, but also in vivo. Furthermore, to evaluate the effect of siRNA-induced L-selectin expression silencing on P388D1 cells metastasis in vivo, siRNA-transfected cells were injected into the footpad of each animal (n=7). The development of lymphoma in each group of mice was compared by constructing Kaplan–Meier survival curves. All non-killed mice died 28 days after the injection of 8 105 P388D1 cells transfected with control siRNA, whereas the death of the mice was delayed significantly after injection of 8 105 P388D1 cells transfected with L-selectin siRNA (Figure 2c). The effect of L-selectin siRNA-induced L-selectin expression silencing was assessed by metastasis rates. The metastasis rates were defined as the proportion of mice, which had metastatic tumor in peripheral lymph nodes determined by standard histological analysis, within group. The results showed that silencing L-selectin expression by L-selectin siRNA dramatically attenuated metastasis of P388D1 cells to popliteal, inguinal and axillary nodes (Figure 2d). In another experiment, 3 106 P388D1-inoculated mice were injected with 500 ng of MEL-14 or 500 ng of rat IgG on the day of tumor inoculation and every 3 days thereafter (n=10). The mice were killed on day 21, and the effect of the antibody treatment was assessed by analysis of metastasis rates (Figure 2d). As compared with control group, the metastasis rate of P388D1 cells to inguinal and axillary nodes, but not popliteal nodes, was significantly reduced in MEL-14 treatment group. In footpad injection model, tumor cells can disseminate to popliteal, inguinal and axillary nodes successively. Our results suggest that a higher expression of L-selection correlates with a later time point of metastasis. Thus, inhibition of P388D1 cells adhesion to lymph node by silencing or blockade of L-selectin on cell surfaces attenuated P388D1 cell colonization in primary lymph nodes and dissemination to secondary lymph organs consequently as well. Taken together, these results indicate that, similar to normal lymphocyte homing mechanisms, P388D1 cells transmigrate to lymph nodes by an L-selectin-dependent mechanism. L-selectin may be as a novel therapeutic target to cure some macrophage-like lymphoid neoplasms. We thank Drs Jianxin Gu (Fudan University, Shanghai, China) and Haiying Chu, Li Jia and Huimin Zhou (Dalian Medical University, Dalian, China) for discussions, Yuejian Liu for technical assistance of flow cytometry analysis. This work was supported by grants from National Natural Science Foundation of China (30470400) and the Science and Technology Department of Liaoning Province, China.